Trial Profile
Double Blind, Multicenter, Randomized, Placebo-controlled, Parallel-group, Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2018
Price :
$35
*
At a glance
- Drugs Lonicera japonica (Primary)
- Indications Gastritis
- Focus Therapeutic Use
- Sponsors GC Biopharma
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 02 Jul 2015 Planned End Date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.
- 02 Jul 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Jul 2015 as reported by ClinicalTrials.gov record.